Savara (SVRA) Exchange Rate Effect (2011 - 2026)
Savara (SVRA) reported Exchange Rate Effect of $74000.0 for Q1 2026, up 346.67% year-over-year from $16567.2 in Q1 2025, and up 305.56% quarter-over-quarter from -$36000.0 in Q4 2025.
Savara (SVRA) Exchange Rate Effect (2011 - 2026) Analysis & Trends
Savara (SVRA) has 12 years of Exchange Rate Effect data on file, last reported at $74000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $74000.0, up 346.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$173000.0 (down 367.57% YoY), and the FY2025 annual result was -$277000.0, down 5440.0% from the prior year.
- Exchange Rate Effect advanced to $74000.0 in Q1 2026 per SVRA's latest filing, from -$36000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $120000.0 in Q4 2022 and troughed at -$145000.0 in Q3 2022.
- A 5-year average of -$24470.6 and a median of -$30000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect tumbled 1600.0% in 2025, then jumped 346.67% in 2026.
- A 5-year view of Exchange Rate Effect shows it stood at $120000.0 in 2022, then tumbled by 73.33% to $32000.0 in 2023, then tumbled by 318.75% to -$70000.0 in 2024, then jumped by 48.57% to -$36000.0 in 2025, then soared by 305.56% to $74000.0 in 2026.
- Business Quant data shows SVRA's Exchange Rate Effect at $74000.0 in Q1 2026, -$36000.0 in Q4 2025, and -$74000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | 74,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74,000.00 |
| Mar 31, 2026 | 74,000.00 |
| Dec 31, 2025 | -36,000.00 |
| Dec 31, 2025 | -36,000.00 |
| Sep 30, 2025 | -74,000.00 |
| Sep 30, 2025 | -74,000.00 |
| Jun 30, 2025 | -137,000.00 |
| Jun 30, 2025 | -137,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Dec 31, 2024 | -70,000.00 |
| Dec 31, 2024 | -70,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Dec 31, 2023 | 32,000.00 |